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IntroductIon
Monocytes arise from common monocyte progenitors 
(cMoPs) in the BM (Hettinger et al., 2013) and develop into 
mature Ly6Chi monocytes before being released into the blood. 
In comparison to other myeloid cells (Terashima et al., 1996), 
monocytes have an exceedingly short transit time through the 
BM and are rapidly released into the circulation after their last 
division (Goto et al., 2003). Upon entering the circulation, Ly-
6Chi monocytes have a half-life of just 20 h before undergoing 
terminal differentiation into longer-lived Ly6Clo monocytes 
(with a half-life of 48 h; Varol et al., 2007; Hanna et al., 2011; 
It is well established that Ly6chi monocytes develop from common monocyte progenitors (cMoPs) and reside in the bone marrow (BM) 
until they are mobilized into the circulation. In our study, we found that BM Ly6chi monocytes are not a homogenous population, as 
current data would suggest. using computational analysis approaches to interpret multidimensional datasets, we demonstrate that BM 
Ly6chi monocytes consist of two distinct subpopulations (cXcr4hi and cXcr4lo subpopulations) in both mice and humans. transcriptome 
studies and in vivo assays revealed functional differences between the two subpopulations. notably, the cXcr4hi subset proliferates and 
is immobilized in the BM for the replenishment of functionally mature cXcr4lo monocytes. We propose that the cXcr4hi subset rep-
resents a transitional premonocyte population, and that this sequential step of maturation from cMoPs serves to maintain a stable pool 
of BM monocytes. Additionally, reduced cXcr4 expression on monocytes, upon their exit into the circulation, does not reflect its di-
minished role in monocyte biology. Specifically, cXcr4 regulates monocyte peripheral cellular activities by governing their circadian 
oscillations and pulmonary margination, which contributes toward lung injury and sepsis mortality. together, our study demonstrates 
the multifaceted role of cXcr4 in defining BM monocyte heterogeneity and in regulating their function in peripheral tissues.
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Mildner et al., 2013; Yona et al., 2013). It is therefore highly es-
sential that circulating Ly6Chi monocytes are constantly being 
replenished through the coordinated release of these cells from 
the BM. Current evidence indicates that the release of BM Ly-
6Chi monocytes is governed by CCR2 and CX3CR1, with 
the latter receptor reportedly influencing the survival of Ly6Clo 
monocytes (Serbina and Pamer, 2006; Landsman et al., 2009; 
Shi and Pamer, 2011; Jacquelin et al., 2013). CXCR4-signaling 
also acts as an anchoring force that retains Ly6Chi monocytes in 
the BM (Jung et al., 2015; Liu et al., 2015), whereas its inhibition 
(Beaussant Cohen et al., 2012; McDermott et al., 2014) reverses 
the observed monocytopenia present in patients with WHIM 
syndrome (Warts, hypogamma-globulinemia, infections, and 
myelokathexis; Hernandez et al., 2003; Gulino et al., 2004).
Although circulating monocytes have historically been 
regarded as precursor cells that replenish tissue macrophages 
and DC populations (Segura and Amigorena, 2013; Varol et al., 
2015), it is now increasingly being recognized that monocytes 
exert potent effector functions at peripheral sites through-
out the body (Mildner et al., 2013). Monocytes comprise 
between ∼4 and 10% of total blood leukocytes and include 
two major subsets that participate in host defense and tissue 
repair (Ginhoux and Jung, 2014). In mice, Ly6Chi monocytes 
resemble human CD14+CD16− classical monocytes (Cros et 
al., 2010; Ingersoll et al., 2010; Wong et al., 2011) that express 
multiple cytokines and granule-associated proteins for effector 
functions at infectious and inflammatory sites (Serbina et al., 
2008). In contrast, murine Ly6Clo monocytes resemble human 
CD14−CD16+ nonclassical monocytes (Cros et al., 2010; In-
gersoll et al., 2010) that patrol and eliminate cellular debris 
from blood vessel walls (Auffray et al., 2007; Carlin et al., 2013), 
as well as control tumor metastasis in the lung (Hanna et al., 
2015). In addition, several studies have shown that monocytes 
mediate the recruitment of leukocytes in response to patho-
logical insults (Kreisel et al., 2010; Carlin et al., 2013), and are 
essential for peripheral tissue repair during the resolution phase 
(Nahrendorf et al., 2010). Consequently, their ability to be rap-
idly mobilized from the BM for their deployment to inflamma-
tory sites, as well as to return to a state of homeostasis, is critical 
for effective immune responses and prevention of collateral tis-
sue damage. Furthermore, monocytes are progressively being 
recognized as attractive targets for therapeutic interventions, as 
lipid nanoparticles and antagonists that target monocytes have 
shown therapeutic efficacy in several diseases (Leuschner et al., 
2011; Majmudar et al., 2013; Poupel et al., 2013). It is therefore 
imperative that a better understanding of their cellular and mo-
lecular mechanisms be explored at multiple tissue levels.
Using a combination of computational analysis ap-
proaches coupled with transcriptome profiling and in vivo 
assays, we identify a previously unknown heterogeneity that 
exists among BM Ly6Chi monocytes in both human and 
mice. Specifically, BM Ly6Chi monocytes consist of two dis-
tinguished subpopulations (CXCR4hi and CXCR4lo subpop-
ulations) and that the immobilized CXCR4hi subset serves 
as a transitional precursor for the replenishment of mature 
CXCR4lo monocytes. Additionally, we provide new insights 
into the role of CXCR4 in mediating the spatiotemporal lo-
calization of monocytes in peripheral sites by demonstrating 
its role in diurnal oscillations and pulmonary margination. Im-
portantly, disruption of CXCR4-signaling also led to reduced 
lung injury and sepsis mortality. Together, our findings identify 
a previously undefined developmental transition that exists 
among BM Ly6Chi monocytes and demonstrates the multi-
faceted role of CXCR4 in their peripheral tissue responses.
reSuLtS
cXcr4 defines heterogeneity among BM Ly6chi monocytes
It is now well established that cMoPs give rise to Ly6Chi 
monocytes in the BM (Hettinger et al., 2013). However, it is 
unclear whether BM Ly6Chi monocytes consist of a homog-
enous population or if further heterogeneity exists among 
these cells. To address this question, we analyzed BM Ly6Chi 
monocytes (excluding their progenitors) using an unsuper-
vised dimensional reduction algorithm (distributed stochastic 
neighbor embedding [t-SNE]; Amir et al., 2013; Becher et al., 
2014) on flow cytometry data based on six common myeloid 
cell markers, CXCR4, CD31, CD16/32, CX3CR1, CCR2, 
and CD11b (Fig. 1 A). This approach allows us to visualize 
multidimensional similarities of cells in a 2D scatter plot, 
known as the t-SNE map, which results in enhanced visual-
ization of small cellular subpopulations through cell clusters 
with similar protein expression patterns (Amir et al., 2013; 
Becher et al., 2014). Visualization of BM Ly6Chi monocytes 
on the t-SNE map revealed heterogeneity among these cells, 
which can be categorized into two main subsets through 
automated clustering (Fig. 1 A). Upon examination of each 
selected marker, we found that CXCR4 delineated BM Ly-
6Chi monocytes into two subsets that closely represented the 
outcome generated by automated clustering (Fig. 1 B). Fur-
thermore, CXCR4 segmentation resulted in the highest ratio 
in median intensity between these two clusters (Fig. 1 C), 
suggesting that CXCR4 could serve as a suitable surface 
marker in delineating BM Ly6Chi monocyte heterogeneity. 
Indeed, we found two distinct populations of Ly6Chi mono-
cytes in the BM that consisted of a CXCR4hi and CXCR4lo 
subset (Fig. 1 D). Furthermore, scanning electron microscopy 
revealed morphological differences between these two sub-
sets, with only the CXCR4lo subset protruding its cytoplas-
mic membrane upon adhering to coverslips (Fig. 1 E). We 
also validate the presence of CXCR4-defined heterogeneity 
among human BM monocytes and observed the presence of 
CXCR4hi and CXCR4lo monocytes (Fig. 1 F). Collectively, 
our results identify heterogeneity in the current established 
BM Ly6Chi monocyte pool and the presence of a distinct 
subpopulation that can be delineated through CXCR4.
transcriptome profiling reveals distinct gene expression 
signatures between BM cXcr4hi and cXcr4lo Ly6chi monocytes
To further characterize the CXCR4hi and CXCR4lo 
monocyte subsets, we sorted all cells in the monocyte 
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developmental pathway, specifically cMoPs, CXCR4hi, 
and CXCR4lo Ly6Chi monocyte subsets, and Ly6Clo 
monocytes from the BM (Fig.  2  A). Subsequently, we 
performed whole transcriptome sequencing using next 
generation sequencing (NGS) on these cells to compare 
their genome-wide RNA expression profiles. Princi-
Figure 1. cXcr4 defines heterogeneity among BM Ly6chi monocytes. (A) BM Ly6Chi monocytes were gated accordingly (left) and subjected to t-SNE 
dimensional reduction (middle). Automatic clustering was performed using k-means, and clusters plotted into the t-SNE map (right). (B) Indicated markers 
are color mapped from blue (low expression) to red (high expression) into the t-SNE map. (C) Overlayed histograms of indicated markers constructed from 
data obtained from the k-means of cluster 1 (blue) and cluster 2 (red) that was generated from automated clustering. (A–C) Data are representative of one 
out of three experiments with at least n = 3 samples. (D–E) BM Ly6Chi monocytes in mice divided into CXCR4hi (blue) and CXCR4lo (red) subsets (D) with 
scanning electron microscopy images of mouse CXCR4hi (top) and CXCR4lo (bottom) subsets (E). Bars, 1 µm. Data are representative of one out of three 
experiments. (F) Gating strategy and division of human BM classical monocytes into CXCR4hi (blue) and CXCR4lo (red) subsets. Data are representative of 
one out of three experiments conducted with seven independent donors.
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pal-component analysis (PCA) of all expressed genes re-
vealed distinct and well-separated transcriptomic profiles 
(Fig.  2  B), implying that the CXCR4hi subpopulation 
was clearly distinct from all other monocyte subsets in 
the BM. In particular, comparative analysis of cMoP and 
the CXCR4hi subset revealed an enrichment of genes 
in the CXCR4hi subset that was predominantly associ-
ated with cell migration and monocyte function, such 
as Fn1, Vcan, Ccr1, Lyz2, and Msr1 (Fig.  2 C). In con-
trast, cMoPs displayed an enrichment of self-renewal 
genes, such as Cd34 and Kit, and neutrophil-associated 
microbicidal activity genes such as Mpo, Ctsg, and Elane 
(Fig.  2  C). Comparative analysis of the CXCR4hi to 
CXCR4lo subset also revealed a significantly large en-
richment of cell cycle–dependent genes in the CXCR4hi 
subset, such as Ccnf, Top2a, Mki67 and Cdk1. In contrast, 
the CXCR4lo subpopulation displayed an enrichment of 
monocyte effector function genes such as Cd14, C5ar1, 
Nod2, and Il1b (Fig. 2 C). Biofunction enrichment anal-
ysis using Ingenuity pathway analysis (IPA; Fig. 2 D) and 
heat maps (Fig. S1) of gene expression data further con-
firmed these findings. In particular, the CXCR4hi subset 
was found to be functionally more mature than cMoPs 
but less mature than the CXCR4lo subset. We also dis-
covered several candidate surface markers that allow the 
discrimination of the CXCR4hi subset from the CXCR4lo 
subset and cMoPs (Fig. 2 E and Fig. S2).
Although BM Ly6Chi monocytes have been thought 
to be terminally differentiated cells that proliferate min-
imally in the steady state (van Furth et al., 1979), the 
enrichment of cell cycle genes in the CXCR4hi subset 
prompted us to determine if these cells may proliferate in 
vivo. To address this, we used a fluorescence ubiquitin cell 
cycle indicator (Fucci) transgenic mouse that labels for 
cells in the S and G2/M phase of the cell cycle. Although 
the CXCR4lo subset and Ly6Clo monocytes were not flu-
orescent for Fucci, the CXCR4hi subset and cMoP were 
found to be Fucci+ and actively cycling in the S/G2/M 
phase (Fig.  2  F). BrdU incorporation assays further re-
vealed that the majority of cells belonging to the CXCR4hi 
subset were in the S phase of the cell cycle, in contrast 
to the CXCR4lo subset that was in the G0/G1 phase 
(Fig.  2  G). Furthermore, we made similar observations 
in human BM cells (Fig. 2 H). Specifically, the CXCR4hi 
subset was found to be actively replicating in the S phase 
of the cell cycle through BrdU incorporation in vitro and 
expressed slightly lower levels of CD14 and CD11b but 
higher levels of HLA-DR (Fig. 2 H). To complement our 
phenotypic studies, we performed an in vivo bead uptake 
assay and confirmed that the CXCR4hi subset was func-
tionally less active than the CXCR4lo subset through re-
duced bead uptake in vivo (Fig. 2 I). Collectively, our data 
distinguishes the CXCR4hi subset as a distinct subpopula-
tion that differs phenotypically and functionally from the 
CXCR4lo subset of Ly6Chi monocytes.
Identification of a developmental relationship between BM 
Ly6chi monocyte subpopulations
To understand how the newly identified CXCR4hi subset 
may relate to monocyte development in the BM, we first 
compared the transcriptomic signature of the CXCR4hi 
subset with signatures specific for both Ly6Chi and Ly6Clo 
monocytes by Connectivity map (CMap) analysis (Fig. 3 A). 
Notably, the CMap analysis is a gene-set enrichment analysis 
algorithm that generates indicative scores of closeness to one 
cell subset of a defined signature gene set (Lamb et al., 2006). 
CMap analysis revealed a skewing of transcriptomic charac-
teristics of the CXCR4hi subset toward the Ly6Chi but not 
Ly6Clo monocyte signature, suggesting that the CXCR4hi 
subset may be an intermediate precursor that bridges the 
cMoP and the CXCR4lo subset (Fig. 3 A). Furthermore, opti-
mal leaf ordering (OLO; Bar-Joseph et al., 2001) of transcrip-
tomic data obtained from cMoP, CXCR4hi, and CXCR4lo 
Ly6Chi monocytes produced a dendrogram that supports the 
appearance of the CXCR4hi subset before the development 
of the CXCR4lo subset (Fig. 3 B). To further understand the 
developmental relationship and phenotypic changes that may 
occur between the CXCR4hi and CXCR4lo subsets, we used 
the Wanderlust algorithm, which orders single cells according 
to their most immature to mature state into a constructed tra-
jectory (Bendall et al., 2014). Based on FACS data that con-
sisted of six parameters indicated in Fig. 1 B, we selected the 
starting point as cells that expressed high levels of CXCR4, 
CD31, and CD16/32 as observed on cMoPs (Fig. 2 E). Based 
on these data, the Wanderlust algorithm computationally de-
termined early events (i.e., immature cells) as CXCR4hiCD-
11bloCCR2loCX3CR1lo cells, whereas late events (i.e., 
mature cells) consisted of CXCR4loCD11bhiCCR2hiCX3 
CR1hi cells (Fig. 3 C). Furthermore, we found that CXCR4, 
CD31, and CD16/32 were down-regulated, whereas CCR2, 
CX3CR1, and CD11b were up-regulated during the course 
of BM Ly6Chi monocyte maturation (Fig. 3 D). These results 
hence strongly suggest that the CXCR4hi subset may be a 
precursor of the mature CXCR4lo subset. To confirm these 
findings in vivo, we adoptively transferred sorted CXCR4hi 
BM Ly6Chi monocytes into recipient mice and observed that 
the CXCR4hi subset differentiated into the CXCR4lo sub-
set (Fig. 3 E). Moreover, administration of BrdU into mice, 
which allowed us to track the maturation of these cells, further 
confirmed the CXCR4hi subset as an immediate precursor of 
the CXCR4lo subset (Fig. 3 F). Notably, we did not detect 
the presence of Ly6Clo monocytes upon the appearance of 
Ly6Chi monocytes in these experiments (unpublished data). 
We also provide evidence that CXCR4 is critically linked 
to BM Ly6Chi monocyte maturation and that the CXCR4lo 
subset represents mature Ly6Chi monocytes that eventually 
egress into the bloodstream during homeostatic conditions 
(Fig. 3, G and H; and Fig. S3). Collectively, our results de-
scribe a previously undefined developmental pathway of 
monocytes and that the CXCR4hi subset acts as an immedi-
ate precursor of mature Ly6Chi monocytes.
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the cXcr4hi subset functions as a transitional 
precursor for the replenishment of active cXcr4lo 
mature Ly6chi monocytes
The circadian rhythmic release of immune cells, in particular 
hematopoietic stem cell progenitors and monocytes, from the 
BM into the circulation represents a fundamental physiolog-
ical process that is integral for host defense and homeostasis 
(Nguyen et al., 2013; Scheiermann et al., 2013). Because our 
current results identify BM Ly6Chi monocytes as a heteroge-
neous population (Figs. 1, 2, and 3), we therefore examined 
their behavior at different periods of the circadian rhythm. 
Here, we observed that only the mature CXCR4lo subset, 
but not the CXCR4hi subset, cMoP, or Ly6Clo monocytes, 
in the BM oscillated in numbers according to the circadian 
rhythm (Fig.  4  A). Although the CXCR4hi subset did not 
exhibit changes in CXCR4 expression, the CXCR4lo subset 
exhibited lower CXCR4 expression and a reduced number 
in the BM at ZT5 (zeitgeber 5; 5 h after the onset of light) 
and a higher CXCR4 expression and number at ZT13 (at 
the beginning of the active phase; Fig.  4  B). These results 
Figure 2. transcriptomics reveal distinct 
expression signatures between the cXcr4hi 
and cXcr4lo Ly6chi monocyte populations. 
(A–E) BM cMoP, CXCR4hi, and CXCR4lo Ly6Chi 
subsets and Ly6Clo monocytes were sorted 
from three individual mice according to the 
gating strategy (A), and then RNA extracted for 
NGS. (B) PCA of gene expression. (C) Volcano 
plots depicting the log2 fold change between 
cMoP and CXCR4hi subset (top) and CXCR4hi 
and CXCR4lo subset (bottom) versus the 
−log10 FDR. (D) Biofunction enrichment anal-
ysis of the top gene-ontology processes that 
are enriched when comparing cMoP versus 
CXCR4hi subset (top) and CXCR4hi versus 
CXCR4lo subset (bottom) using IPA. (E) Heat 
maps of gene expression (log2 CPM; top) and 
surface markers validated by flow cytome-
try (log2 MFI; bottom). Flow cytometry data 
are representative of one out of three exper-
iments. (F) Frequency of proliferating cells 
among BM monocyte subsets determined by 
Fucci-474 mice in vivo. Numbers in histograms 
(top) represent percentage of proliferating 
cells. Results (bottom) are expressed as mean ± 
SD (n = 3) and representative of two indepen-
dent experiments. ****, P < 0.0001 (one-way 
ANO VA). (G) Mouse monocyte subsets in cell 
cycle stages assessed through BrdU incorpo-
ration in vivo. Results are expressed as mean 
± SD (n = 5) and representative of two inde-
pendent experiments. ****, P < 0.0001 (one-
way ANO VA). (H) Human BM cells were pulsed 
with 10 µM of BrdU in vitro and monocytes in 
the S phase (left) were found to be CXCR4hi, 
CD11blo, CD14lo, and HLA-DRhi (right). Results 
are representative of one out of four indepen-
dent donors. (I) BM mouse monocytes subsets 
were assessed for their uptake of microspheres 
in vivo after 4 h through flow cytometry. Re-
sults are expressed as mean ± SD (n = 5) and 
representative of two independent experi-
ments. **, P < 0.01 (one-way ANO VA).
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hence suggest that both subsets of monocytes may display 
a difference in their mobilizing capacity. Therefore, we next 
determined how a strong mobilizing cue, such as LPS (Shi et 
al., 2011; Evrard et al., 2015), may impact their mobilization. 
Intriguingly, we observed that LPS administration resulted in 
the egress of the CXCR4lo subset and Ly6Clo monocytes, 
but not the CXCR4hi subset and cMoP in the BM (Fig. 4, 
C and D). Further analysis demonstrated that the CXCR4hi 
subpopulation displayed a much lower surface expression of 
CCR2 (Fig. 4 E), which led to a drastically poorer migration 
toward the cognate ligand CCL2 (Fig.  4 F). Together with 
our transcriptomic and functional data (Fig.  2), our results 
hence indicate that the CXCR4hi subpopulation is essentially 
immobilized in the BM under both homeostatic and inflam-
Figure 3. Identification of a developmen-
tal relationship between subpopulations 
of BM Ly6chi monocytes. (A) CMap analysis 
of cMoP, CXCR4hi subset, CXCR4lo subset, and 
Ly6Clo monocytes displaying their enrichment 
for Ly6Chi or Ly6Clo monocyte gene sets. (B) 
OLO reveals a computationally determined de-
velopmental order that starts with the cMoP 
and ends with the CXCR4lo subset as the most 
mature cell type. (A and B) Data were analyzed 
using transcriptomic data obtained from three 
individual mice. (C and D) BM Ly6Chi mono-
cytes subjected to the Wanderlust algorithm 
using flow cytometry data of six parameters. 
Data are representative of one out of three 
independent experiments. (C) Events were 
plotted against the wanderlust parameter 
with low and high values representing early 
and late predicted events, respectively. Early 
and late events were next plotted for CXCR4 
expression against CD11b, CCR2, and CX3CR1. 
(D) Wanderlust traces showing low CXCR4, 
CD31, and CD16/32 during the early trajectory 
(0–0.5), and an increase in CX3CR1, CCR2, and 
CD11b during the late trajectory (0.5–1). (E) In-
trafemoral transfer of sorted CD45.1+ CXCR4hi 
subset into CD45.2 recipients. Blue dots repre-
sent transferred cells after 8 and 24 h. Results 
are representative of one out of five mice in 
three independent experiments. (F) FACS plots 
of BrdU+ (blue) and BrdU− (red) Ly6Chi mono-
cytes after BrdU administration. Results are 
representative of one out of five independent 
mice. (G) Alteration in CXCR4 expression over 
time among BM Ly6Chi monocytes (left) and 
percentage of BrdU+ Ly6Chi monocytes in the 
blood (right) at various time points. ΔMFI was 
calculated by subtracting the CXCR4 MFI of 
BrdU− Ly6Chi monocytes from that of BrdU+ 
Ly6Chi monocytes (as described in Fig. S3). Re-
sults are expressed as mean ± SEM (n = 5) and 
representative of one out of two independent 
experiments. (H) Graph showing correlation 
between blood BrdU+ Ly6Chi monocytes and 
ΔMFI of CXCR4 in the BM. Each dot represents 
one data time point and significance was de-
termined using a Pearson correlation test.
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matory conditions to serve as a transitional precursor for the 
replenishment of CXCR4lo mature monocytes.
cXcr4 mediates circadian rhythmic oscillations of mature 
monocytes and their homing into reservoirs
In contrast to the heterogeneity observed in the BM, we found 
that circulating Ly6Chi monocytes (Fig. S4) were exclusively 
CXCR4loCD11bhi cells (Fig. 5 A). However, it remains un-
clear if the reduced expression of CXCR4 upon their exit 
from the BM indicates its diminished role in peripheral tissue 
compartments. Because BM CXCR4loLy6Chi monocytes was 
found to exhibit diurnal fluctuations in CXCR4 expression 
(Fig. 4, A and B), we hence examined whether such physi-
ological and cellular rhythms could also occur among circu-
lating monocytes. We also determined if CXCR4 mediates 
these physiological processes by studying their diurnal oscilla-
tions in a conditional knockout mouse (Lyz2creCxcr4fl mice) 
that permits efficient and selective deletion of the Cxcr4 gene 
Figure 4. BM Ly6chi monocyte subpopulations represent two distinct mobilizable pools. (A and B) BM monocyte subsets (cMoP, CXCR4hi and CXCR4lo 
Ly6Chi monocytes, and Ly6Clo monocytes) were quantified for their numbers (A) and their normalized CXCR4 MFI (B) at ZT5 and ZT13. Results are expressed 
as mean ± SD (n = 4–5) and representative of one out of three experiments. ns, not significant; *, P < 0.05; **, P < 0.01 (Student’s t test). (C) BM monocyte 
subset counts after LPS administration. Results expressed as mean ± SD (n = 5) and representative of one out of five independent experiments. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001 (one-way ANO VA). (D) BrdU+ CXCR4hi and CXCR4lo subset counts after 2 h of LPS administration. Results expressed as mean ± SD 
(n = 5) and representative of one out of three independent experiments. ns, not significant; ***, P < 0.001 (Student’s t test). (E) CCR2 expression (left) and 
CCR2 MFI (arbitrary units; right) of CXCR4hi and CXCR4lo subsets. Results are expressed as mean ± SEM (n = 5). ****, P < 0.0001 (Student’s t test). (F) Che-
motaxis assay of CXCR4hi and CXCR4lo subsets towards CCL2. Results expressed as mean ± SD (n = 5) and representative of two independent experiments. 
*, P < 0.05; **, P < 0.01 (two-way ANO VA).
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in myeloid lineage cells, such as monocytes and neutrophils 
(Clausen et al., 1999; Fig.  5, B and C). Indeed, we found 
that circulating monocytes exhibited fluctuations in CXCR4 
expression (Fig. 5, D and E) that corresponded to the high 
and low number of circulating Ly6Chi (Fig. 5 D) and Ly6Clo 
monocytes (Fig. 5 E) at ZT5 and ZT13, respectively. More 
importantly, this diurnal oscillation in monocyte numbers was 
abrogated in the absence of CXCR4 (Fig. 5, D and E) and 
highlights the role of CXCR4 in mediating the diurnal vari-
ations in circulating monocyte numbers.
Although it is likely that circadian-mediated fluctua-
tions in CXCR4 expression could influence the release of 
monocytes from the BM and impact on the overall numbers 
of circulating monocytes, we hypothesize that this process 
may also act on the trafficking patterns of monocytes in pe-
ripheral compartments. To test this hypothesis, we established 
parabiosis between CD45.1 WT mice and CD45.2 CXCR4 
genetic-modified mice (Fig.  6, A and B). CXCR4 genet-
ic-modified mice included either Lyz2creCxcr4fl mice or a 
knock-in mouse strain that carries a CXCR4 gain-of-function 
mutation characteristic of WHIM patients (termed Cxcr4WHIM 
or WHIM mice; Balabanian et al., 2012; Beaussant Cohen 
et al., 2012; McDermott et al., 2014). The homing ratio of 
cells were then calculated (Fig. 6 A) to normalize for their 
chimerism (Fig.  6 C). Using this approach, we observed a 
significant decrease in the homing of Lyz2creCxcr4fl mono-
cytes to the BM (Fig. 6 A). This trend was similarly observed 
with neutrophils (Fig. 6 A) and is consistent with the known 
requirement of CXCR4 in mediating their homing to the 
BM (Martin et al., 2003; Suratt et al., 2004; Devi et al., 2013). 
Figure 5. cXcr4 regulates circadian rhythmic oscillations of monocytes. (A) Representative FACS plot of CXCR4 and CD11b expression by blood 
Ly6Chi monocytes (gating strategy in Fig. S4) of one out of four independent experiments. (B) Representative FACS plot depicting loss of CXCR4 expression 
in Lyz2creCxcr4fl mice (blue) as compared with Cxcr4fl controls (red) of one out of three independent experiments. (C) Comparison of blood leukocyte 
populations in RosamT/mG :Lyz2cre mice and RosamT/mG :Lyz2creCxcr4fl mice showing the percentage of Lyz2-cre mediated recombination (GFP+) at the Rosa26 
locus (left) and normalized CXCR4 MFI (arbitrary units) of circulating leukocyte subsets (right). Results are expressed as mean ± SD (n = 4–5 mice per group). 
ns, not significant; *, P < 0.05; **, P < 0.01; ****, P < 0.0001 (two-way ANO VA). (D and E) Blood Ly6Chi (D) and Ly6Clo (E) monocyte values of normalized 
CXCR4 MFI on Cxcr4fl control mice (left) and counts between Cxcr4fl control and Lyz2creCxcr4fl mice (right) were quantified at ZT5 and ZT13. Data are 
representative of one out of three experiments. Results are expressed as mean ± SD (n = 5 mice per group). ns, not significant; **, P < 0.01; ***, P < 0.001; 
****, P < 0.0001 (Student’s t test).
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In contrast, no significant differences in T cell homing ratio 
were observed between the Lyz2creCxcr4fl and WT parabionts 
as T cells are not targeted by the Lyz2cre-mediated deletion 
of CXCR4 (Eash et al., 2009; Fig. 6 A) and confirms that 
our earlier observations on monocytes are cell intrinsic and 
specifically mediated by CXCR4. In contrast, WHIM mice 
exhibited a corresponding increase in monocyte homing to 
the BM in their WT partners (Fig. 6 B). Adoptive transfer 
experiments further confirmed these findings, as CD45.1 BM 
monocytes that were transferred into CD45.2-recipient mice 
were observed to rapidly decline in the blood and accumulate 
in the BM via a mechanism that was disrupted by AMD3100 
treatment (Fig. 6, D and E). Interestingly, we also observed a 
significant decrease in the homing of Lyz2creCxcr4fl mono-
cytes into the spleen (Fig. 6 A). Conversely, there was a trend 
toward an increased homing of WHIM monocytes into the 
spleen (Fig. 6 B). Collectively, our data highlights a role for 
CXCR4 in mediating the circadian rhythmic fluctuations in 
the overall number of circulating Ly6Chi monocytes and their 
homing into tissue reservoirs.
circulating monocytes accumulate in the pulmonary 
vasculature after endotoxin exposure
It is well established that LPS administration is a potent me-
diator that mobilizes monocytes from the BM, and conse-
quently results in increased circulating monocyte numbers 
(Shi et al., 2011; Evrard et al., 2015). However, we consistently 
observed a transient phase of monocytopenia in the blood 
that occurs one hour after LPS administration (Fig.  7  A), 
which corresponded to a time point whereby no significant 
changes in monocyte numbers were detected in the BM 
(Fig.  4  C). These results hence suggest that blood mono-
cytes were possibly being withdrawn temporarily from the 
circulation into other tissues. To address this hypothesis, we 
adopted an intravascular staining protocol (Reutershan et al., 
2005; Ng et al., 2011; Anderson et al., 2014; Fig. 7 B), which 
allowed discrimination between intravascular or extravascular 
cell distributions in tissues in vivo. In the lung, this approach 
confirmed the extravascular location of alveolar macrophages, 
whereas monocytes and neutrophils were identified as being 
intravascular (Fig. 7 C). Using this method, we found that 
the LPS-induced decrease in circulating monocytes was ac-
companied by a gradual accumulation of these cells in the 
intravascular compartment of the lung (Fig.  7, D and E), 
with limited monocyte sequestration into other major organs 
(spleen, liver, and kidney; unpublished data). Furthermore, this 
phenomenon was mediated by the intrinsic sensing of LPS by 
monocytes and not vascular stromal cells, as our BM chimeric 
data demonstrated an abrogation of monocyte accumulation 
in the lung in the absence of TLR4 in the hematopoietic 
compartment (Fig. 7 F). Therefore, these data suggests that 
circulating monocytes are transiently withdrawn from the 
circulation and sequestered into the lung microvasculature in 
response to systemic inflammatory stimuli.
cXcr4 regulates monocyte margination in 
the pulmonary vasculature
To delineate the mechanism of LPS-induced monocyte ac-
cumulation in the lung, we used intravital two-photon mi-
croscopy to visualize the pulmonary microvasculature of 
Cx3cr1gfp/+ reporter mice. Endotoxin exposure stimulated 
blood monocytes to alter their morphology and decrease 
their velocity in the lung capillaries, which are characteris-
tic features of margination (Doerschuk et al., 1993; Kuebler 
and Goetz, 2002; Looney and Bhattacharya, 2014; Fig. 8 A 
and Video 1). Because lung endothelial cells express CXCL12 
(Devi et al., 2013), we speculated that the CXCL12–CXCR4 
signaling axis might be involved in monocyte margination 
in the lung. To test this hypothesis, we treated Cx3cr1gfp/+ 
mice with AMD3100 and observed monocytes traveling 
through the lung microcirculation at a higher velocity and 
with significant reduced adherence to the endothelium, even 
in mice that were treated with the promargination stimulus 
LPS (Fig.  8, B and C; and Video 1). FACS analysis further 
supported these data, as shown by increased accumulation of 
lung monocytes in WHIM mice after LPS challenge, whereas 
this phenomenon was abrogated in Lyz2creCxcr4fl mice 
(Fig. 8 D). Because it is well known that Ly6Chi monocytes 
also express lower levels of GFP in Cx3cr1gfp/+ mice (Auffray 
et al., 2007), we ensured that our approach was able to detect 
Ly6Chi monocytes during intravital imaging by administering 
an anti-Ly6B.2 antibody into Cx3cr1gfp/+ mice to stain these 
cells in vivo (Fig. 8, E and F; and Video 2) and confirmed that 
our imaging approach accounted for these cells.
We next further determined whether CXCR4 reg-
ulated monocyte margination equally in both subsets. By 
using a lung efflux assay to quantify monocyte release from 
the pulmonary circulation (Devi et al., 2013; Fig. 9 A) with-
out the interference from interposing organs (Bierman et 
al., 1952), we observed that AMD3100 treatment increased 
the net release of both Ly6Chi and Ly6Clo monocytes from 
the lungs (Fig. 9 B). However, only the Ly6Chi subset dis-
played a significant increase in lung retention following 
LPS and this process could be prevented with the pread-
ministration of AMD3100 (Fig. 9 B). To extend these find-
ings in the context of humans, we found that AMD3100 
also markedly increased circulating CD14+CD16− classical 
monocytes in humanized mice, which was accompanied 
by an increased net release of these cells from the pulmo-
nary circulation (Fig.  9, C and D). This phenomenon was 
similarly observed in an experimental model of non-hu-
man primates (Fig. 9 E).
The accumulation of myeloid cells in the lung is a hall-
mark of injury in pulmonary diseases (MacNee and Selby, 
1993). It is thus likely that an increase in margination in 
the lung endothelium may predispose toward tissue injury. 
To test this hypothesis, we used a model of acute lung in-
jury (ALI; O’Dea et al., 2009) and found that Lyz2creCxcr4fl 
mice displayed a significant decrease in vascular leakage com-
pared with the Cxcr4fl control mouse (Fig.  9  F). Further-
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Figure 6. cXcr4 regulates homing of monocytes back to reservoirs. (A and B) Homing capacity (calculated as a ratio) of monocytes or indicated 
immune cells of WT and Lyz2creCxcr4fl (A) or Cxcr4WHIM (B) into the BM or spleen of their respective partners in parabiotic mice. Monocyte, neutrophil and T 
cell numbers were quantified in blood, BM and spleen before calculation of the respective homing ratios to normalize for unequal exchange in circulating 
leukocytes (n = 4–5). ns, not significant; *, P < 0.05; **, P < 0.01 (Student’s t test). Results are representative of one out of two independent experiments. 
(C) Percentage of nonhost cells present in blood of WT and Lyz2creCxcr4fl mice (left), and WT and Cxcr4WHIM parabiotic mice (right). Results are expressed as 
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more, Ly6Chi monocytes did not accumulate in the lungs of 
Lyz2creCxcr4fl mice in a high-grade cecal ligation and puncture 
(CLP) model of sepsis (Fig. 9 G) and exhibited a significant 
improved survival outcome compared with Cxcr4fl control 
mice (Fig.  9 H). Together, these data suggest that CXCR4 
continues to play important roles in regulating monocyte 
margination in the pulmonary circulation, whereas disruption 
of its signaling ameliorated lung injury and sepsis mortality.
dIScuSSIon
In this study, we report the discovery of heterogeneity among 
BM Ly6Chi monocytes. Specifically, BM Ly6Chi monocytes 
consist of two developmentally related subsets of monocytes 
(CXCR4hi and CXCR4lo subpopulations) that are function-
ally distinct in their immunological roles. Furthermore, we 
extend the role of CXCR4 beyond its reported function as a 
mere BM anchoring signal by demonstrating its involvement 
in the control of monocyte tissue trafficking activities. Specif-
ically, we reveal that CXCR4 controls monocyte margination 
in the lung vasculature and contributes to lung injury and 
sepsis-induced mortality. Our study hence provides a concep-
tual advancement in the understanding of monocyte biology 
by identifying the presence of a transitional precursor pop-
ulation among BM Ly6Chi monocytes and deciphering the 
peripheral mechanisms that control monocyte homeostasis 
in the tissue (Fig. 10).
Using a combination of computational analytical ap-
proaches and flow cytometric analysis, we observed that 
cMoP-derived BM Ly6Chi monocytes consist of two distinct 
subpopulations defined by CXCR4 expression. Isolation of 
these cells revealed that CXCR4hi and CXCR4lo subpopula-
tions are transcriptionally distinct. In particular, the CXCR4hi 
subpopulation was enriched in genes associated with cell 
cycle, cell division, and DNA repair whereas the CXCR4lo 
subpopulation was over-represented with genes associated 
with cellular activation, phagocytosis, motility, and pattern 
recognition. Comparative analysis of the CXCR4hi subpopu-
lation with its progenitor, cMoP, also revealed distinct genetic 
differences, with the CXCR4hi subset displaying a more ma-
ture phenotype than cMoPs. Our results hence suggest that 
a considerable amount of functional maturation continues to 
occur in the CXCR4hi subpopulation. Consistent with this 
notion, results from our functional studies validated that the 
CXCR4hi subpopulation is actively proliferating and dis-
played reduced bead internalization in vivo compared with 
the CXCR4lo subpopulation. More importantly, we show that 
the CXCR4hi subpopulation gives rise to mature CXCR4lo 
Ly6Chi monocytes over time. Furthermore, this CXCR4hi 
subpopulation, like cMoPs, remains immobilized in the BM 
even under inflammatory conditions and is insensitive to-
ward circadian rhythmic fluctuations. Together, we propose 
that the CXCR4hi subpopulation of BM Ly6Chi monocytes 
represents a population of transitional premonocytes (TpMo). 
It is noteworthy that although Hettinger et al. (2013) have 
shown the cMoP to be the only subset in the BM monocyte 
fraction to form colonies and is committed strictly toward 
monocyte development, it remains unclear if cMoPs are fully 
committed toward the Ly6Chi monocyte lineage, or may give 
rise to Ly6Clo monocytes independent of their differentiation 
from Ly6Chi monocytes (Thomas et al., 2015). Because our 
CMap analysis and in vivo data strongly demonstrates a linear 
development of Ly6Chi monocytes from TpMo, it is likely 
that the loss of c-kit on TpMo represents a loss of self-renewal 
ability (Ogawa et al., 1991) upon their differentiation from 
cMoPs, and that TpMos differ from cMoPs by serving as the 
first fully committed and immediate precursor of mature Ly-
6Chi monocytes. More importantly, we believe that this newly 
defined developmental transition forms a regulatory check-
point that prevents an uncontrolled release and allows for 
the rapid replenishment of BM monocytes. Our results also 
suggest a new working model whereby monocytes program 
their intrinsic mobilizing capacity according to their func-
tional maturity, which ensures that only functionally mature 
monocytes are being mobilized into the circulation.
It is well established that CXCR4-signaling plays a crit-
ical role in multiple biological processes in the BM compart-
ment (Nagasawa, 2014). Consequently, studies have implicated 
a role for CXCR4 in monocyte retention in the BM (Jung 
et al., 2015; Liu et al., 2015). However, it remains unclear if 
reduced expression of CXCR4 on monocytes, upon their 
exit from the BM, indicates its diminished role in monocyte 
biology in the circulation. Contrary to this assumption, we 
observed that CXCR4 functions as an important mediator 
in the spatiotemporal localization of monocytes in periph-
eral compartments. Notably, monocytes have been shown 
to shuttle back to the BM through an unknown mechanism 
(Varol et al., 2007). Using parabiosis and adoptive transfer 
approaches, we provide the first experimental evidence of 
CXCR4-mediated BM homing as a key mechanism in reg-
ulating circulating monocyte numbers, which is in line with 
postulations discussed by Wang et al. (2009). Furthermore, we 
found a similar trend in CXCR4-dependent homing into the 
spleen, which further supports the idea that the spleen con-
tains a reservoir of bona fide monocytes (Swirski et al., 2009) 
that is not simply synonymous with the blood pool. Although 
we believe that the BM remains the major compartment 
where circulating monocytes home to as the spleen reser-
voir (Swirski et al., 2009) and its CXCL12 expression (Inra 
et al., 2015) are much smaller than that of the BM, splenic 
monocytes are mobilized during vascular and ischemic injury 
mean ± SD (n = 4–5) and representative of one out of two independent experiments. (D and E) Total number of donor (CD45.1+) monocytes with a Ly6Chi 
(left) or Ly6Clo (right) phenotype detected in blood (D) or BM (E) in recipient CD45.2+ mice that had been pretreated with or without AMD3100. Results are 
expressed as mean ± SD (n = 4) and representative of one out of three independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (two-way ANO VA).
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Figure 7. endotoxemia promotes monocyte retention in the pulmonary circulation. (A) Blood Ly6Chi (top) and Ly6Clo (bottom) monocyte counts after 
i.v. treatment with 10 ng LPS. Results are expressed as mean ± SEM (n = 4) and representative of one out of three independent experiments. ns, not signifi-
cant; *, P < 0.05; **, P < 0.01; ****, P < 0.0001 (one-way ANO VA). (B) Illustration showing the intravascular labeling of leukocytes with anti-CD45 antibodies. 
(C) Representative flow cytometry plots showing the extravascular and intravascular localization of lung immune cells of one out of three independent 
experiments. (D and E) Quantification of Ly6Chi (left) and Ly6Clo (right) monocytes in blood (D) and lung tissues (E) from LPS-treated mice. Results are ex-
pressed as mean ± SEM (n = 4) and representative of one out of four experiments. ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 
(one-way ANO VA). (F) WT and Tlr4−/− chimeric mice were analyzed for Ly6Chi monocyte numbers after 1 h of LPS administration. Each data point represents 
one individual mouse and results are representative of two individual experiments. ns, not significant; **, P < 0.01 (one-way ANO VA).
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and increase in numbers through extramedullary hematopoi-
esis (Leuschner et al., 2012; Robbins et al., 2012). Therefore, 
future work would be required to determine the extent of 
monocyte homing to the spleen in these scenarios.
Leukocytes rely heavily on the circulatory system to 
transport themselves to various tissues/organs. During this 
trafficking process, leukocytes may interact with endothelial 
cells for prolonged periods of time, which determines their 
transit time in organs. However, the functional outcomes of 
these leukocyte intravascular activities have been underap-
preciated. It has been proposed that the marginated pool is 
caused by the need for leukocytes to alter their morphology 
as they transit and crawl through small-caliber microvessels 
(Kuebler and Goetz, 2002). In particular, the lung represents 
a major site of leukocyte margination (Staub and Schultz, 
1968; Hogg, 1987) and is the only organ to receive the full 
Figure 8. Monocytes marginate in the 
pulmonary vasculature. (A) A representative 
GFP+ monocyte (arrowhead) alters its mor-
phology through pulmonary capillaries. Bar, 
15 µm (time, h:mm:ss; green, CX3CR1+ cells; 
red, TRI TC-dextran). Results are representa-
tive of one out of three independent experi-
ments. (B and C) Monocyte mean velocity (B) 
and duration of adherence (C) after indicated 
treatments. Results are pooled from three in-
dependent experiments per treatment and are 
expressed as mean ± SEM. ns, not significant; 
**, P < 0.01; ***, P < 0.001; **** P < 0.0001 (one-
way ANO VA). (D) LPS-induced fold-increase in 
lung Ly6Chi (left) and Ly6Clo (right) monocytes 
1 h after treatment. Results expressed as mean 
± SEM (n = 4–7). ns, not significant; *, P < 0.05; 
***, P < 0.001 (one-way ANO VA). (E) Snapshots 
of GFP+ monocytes in the lung of a Cx3cr1gfp/+ 
reporter mouse, before (top) and after (bot-
tom) i.v. administration of a Ly6B.2-PE anti-
body (4 µg). A representative GFP+ monocyte 
is depicted migrating through pulmonary 
capillaries (white track), becomes PE+ after an-
tibody administration Bar, 15 µm (time, h:m-
m:ss; green, CX3CR1+ cells; red, Ly6B.2+ cells; 
blue, Evans blue). Results are representative 
of one out of three independent experiments. 
(F) FACS plots of lungs from Cx3cr1gfp/+ mice 
i.v. injected with Ly6B.2-PE. Ly6Chi (red), Ly6Clo 
monocytes (orange), and neutrophils (green) 
were plotted in relation to Ly6B.2 expression. 
Results are representative of one out of three 
independent experiments.
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cardiac output. Previous studies have shown that leukocyte 
margination depends on a balance between the propelling 
force executed by the shear stress of blood flow (Martin et al., 
1982) and a retaining force that delays monocyte transit. Data 
from our intravital imaging and lung efflux experiments sug-
gest that CXCR4 interactions partly constitute the retention 
force in the lung vasculature. Importantly, we were able to 
successfully replicate these findings in both humanized mice 
and in a nonhuman primate model, suggesting that CXCR4 
regulation of monocyte margination is likely to be physiolog-
ically relevant in humans.
Although leukocyte margination is a fundamental 
physiological process, their dysregulated intravascular migra-
tion and uncontrolled aggregation are associated with sev-
eral human inflammatory diseases (MacNee and Selby, 1993; 
Looney and Bhattacharya, 2014). Here, we show that LPS 
Figure 9. cXcr4 regulates pulmonary monocyte margination and predisposition to injury. (A) Schematic of the lung efflux assay. (B) Monocyte 
numbers released from the lung vasculature after indicated treatments. Results expressed as mean (n = 5–7 per group) and representative of one out of 
three independent experiments. ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001 (one-way ANO VA). (C and D) Frequency of blood (C) and pulmonary 
release (D) of CD14+CD16− classical monocytes in humanized mice at baseline and 2 h after AMD3100 treatment (n = 8–11). Results are representative 
of one out of two independent experiments. **, P < 0.01 (Student’s t test). (E) Net monocyte release from the lungs of two individual nonhuman primates 
(Macaca fascicularis) over a 4-h observation period. (F–H) Lyz2creCxcr4fl mice were compared with Cxcr4fl control mice for lung vascular leakage during 
acute lung injury (F; n = 5; **, P < 0.01, Student’s t test) or fold-increase accumulation of lung Ly6Chi (left) and Ly6Clo (right) monocytes (G; n = 3–5; ***, P < 
0.001, Student’s t test) and their mortality using the Kaplan-Meier survival curve (H; n = 10; ****, P < 0.0001, Mantel-Cox) in the CLP sepsis model. Results 
are representative of one out of three independent experiments.
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triggers increased pulmonary accumulation of inflammatory 
Ly6Chi monocytes that leads to lung injury but is ameliorated 
by CXCR4 inhibition. On the other hand, it appeared that 
CXCR4 did not play a significant role in Ly6Clo monocyte 
margination during endotoxemia, suggesting that Ly6Clo 
monocytes may use a different array of molecules to interact 
with the endothelium, such as integrins, as supported by a 
previous study (Carlin et al., 2013). Nevertheless, our study 
provides a mechanistic understanding of how CXCR4 antag-
onism may attenuate lung inflammatory diseases, as described 
by previous studies (Lukacs et al., 2002; Drummond et al., 
2015). Furthermore, we show that interfering with CXCR4 
signaling results in reduced monocyte accumulation in the 
lung, which was associated with increased sepsis survival. No-
tably, although monocytes are essential for bacteria clearance, 
they are also major contributors of the cytokine storm that 
leads to organ damage and mortality (Weber et al., 2015). Fur-
thermore, monocyte depletion during ALI has been shown to 
improve the outcome of vascular injury (O’Dea et al., 2009; 
Dhaliwal et al., 2012). However, it is important to note that 
more experimental work would be required to determine the 
immune and organ-specific contexture of monocyte margin-
ation in the lung. Hence, our study shows that CXCR4-me-
diated monocyte compartmentalization may serve as a major 
biological regulatory mechanism that underlies immune ho-
meostasis to prevent excessive damage to the host.
In summary, our study provides new insight into the 
current framework of monocyte development and homeo-
stasis by identifying a previously undescribed population of 
TpMo among BM Ly6Chi monocytes. Furthermore, our re-
sults extend the role of CXCR4 beyond its function as a BM 
retentive force to an important regulator in the peripheral 
Figure 10. cXcr4 identifies a tpMo pop-
ulation in the BM and mediates monocyte 
cellular responses in peripheral tissues. 
(top) Monocytes arise from cMoPs and un-
dergo a developmental pathway that ends 
with Ly6Clo monocytes as the terminally dif-
ferentiated form of monocytes. In this study, 
we propose that cMoP-differentiated Ly6Chi 
monocytes undergo a developmental transi-
tion, which involves a transitional premono-
cyte (TpMo) stage, before giving rise to mature 
Ly6Chi monocytes. TpMos are identified based 
on their CXCR4hi expression compared with 
mature Ly6Chi monocytes that are CXCR4lo. 
Furthermore, TpMos can be distinguished from 
cMoPs based on their negative expression for 
c-kit. Functionally, TpMos are immobilized 
in the BM to serve as an immediate precur-
sor for the active pool of mature CXCR4lo 
Ly6Chi monocytes. (Bottom) Upon entering 
the circulation, CXCR4 plays a significant 
role in monocyte margination in the pulmo-
nary vasculature. Exposure to subclinical LPS 
doses triggers increased pulmonary mono-
cyte margination, leading to a transient state 
of monocytopenia that can be reversed with 
CXCR4 inhibition using AMD3100. Disruption 
in CXCR4 signaling also attenuated lung injury 
and prevented sepsis mortality.
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tissue compartment with implications in pulmonary inflam-
mation. Hence, we envision that our results will provide a 
new framework for understanding monocyte biology and 
may lead to the engineering of improved monocyte-targeting 
therapeutic strategies.
MAterIALS And MethodS
Mice and treatments
C57BL/6 mice (6–10-wk-old) were bred and maintained 
under specific pathogen–free conditions in the Biological 
Resource Centre (BRC) of A*STAR, Singapore. Lyz2cre/cre 
(B6.129P2-Lyz2tm1(cre)Ifo/J), Cx3cr1gfp/+ (B6.129P-
Cx3cr1tm1Litt/J), Cxcr4fl/fl (B6.129P2-Cxcr4tm2Yzo/J), NOD-scid 
Il2rg−/− (NSG; NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ), Rosa26mT/mG 
(STO CK Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J), and CD45.1 
mice were obtained from The Jackson Laboratory. Fucci-474 
mice were from the Institute of Physical and Chemical Research 
BioResource Center (Ibaraki, Japan; Sakaue-Sawano et al., 
2013). Lyz2cre/cre mice were crossbred in-house with Cxcr4fl/fl 
mice to generate progeny that were CXCR4-deficient in 
the myeloid lineage only (termed Lyz2creCxcr4fl; Eash et al., 
2009). Tlr4−/− mice were obtained from Oriental BioService. 
Gain-of-function Cxcr41013/+ mice (termed Cxcr4WHIM) were 
provided by F. Bachelerie (Balabanian et al., 2012). For fate-
mapping purposes, LyzcreCxcr4fl were crossed to Rosa26mT/mG 
mice (termed RosamT/mG :LyzcreCxcr4fl). Humanized mice 
were generated as described (Chen et al., 2013). All transgenic 
mice were maintained on a C57BL/6 background and 
experiments were performed under the approval of the 
Institutional Animal Care and Use Committee (IAC UC) of 
the BRC, in accordance with the guidelines of the Agri-Food 
and Veterinary Authority (AVA) and the National Advisory 
Committee for Laboratory Animal Research (NAC LAR) 
of Singapore. Mice were treated with 5mg/kg AMD3100 
(plerixafor; Sigma-Aldrich) via subcutaneous injection and/
or with 10 ng LPS derived from Escherichia coli (serotype 
O55:B5; Alexis Biochemicals) administered via intravenous 
route. All experiments were performed between ZT4 to ZT8 
unless otherwise stated.
tissue preparation for flow cytometry and sorting
Blood was obtained via cardiac puncture or incision in the 
submandibular region and was then treated with commercial-
grade red blood cell lysis buffer (eBioscience). Lungs were 
removed en bloc in experiments looking at pulmonary 
margination and mice were perfused with PBS containing 
2  mM EDTA using a peristaltic pump (MIN IPU LS 3; 
Gilson), followed by removal of the spleen and femurs. Lungs 
and spleens were finely minced and homogenized to single-
cell suspensions using 70-µm nylon mesh sieves with syringe 
plungers (O’Dea et al., 2009). Mice femurs were flushed 
and the effluent passed through a 70-µm nylon mesh sieve 
to obtain a BM cell suspension. Human BM mononuclear 
cells were purchased from Lonza and processed according to 
the manufacturer’s instructions. Antibodies were purchased 
from eBioscience, BioLegend, BD, or R&D Systems. Mouse 
cells were stained with the following antibodies: CCR2 
(475301), CD3e (145-2C11), CD4 (GK1.5), CD8 (53–6.7), 
CD11b (M1/70), CD11c (N418), CD16/32 (93), CD19 
(eBio1D3), CD31 (390), CD34 (RAM34), CD43 (S7), 
CD45 (30-F11), CD45.1 (A20), CD45.2 (104), CD45R/
B220 (RA3-6B2), CD49a (HMα1), CD49f (GoH3), CD62L 
(MEL-14), CD71 (YTA74.4), CD88 (20/70), CD115 
(AFS598), CD172a (P84), CD274 (10F.9G2), cKit (2B8), 
CXCR4 (2B11), CX3CR1 (SA011F11), F4/80 (CI :A3 -1), 
Flt3 (A2F10), IA-IE (M5/114.152), Ly6C (HK1.4), Ly6G 
(1A8), NK1.1 (PK136), and Ter119 (TER-119). Human 
cells were stained with the following antibodies: CD3 
(UCHT1), CD10 (eBioCB-CAL LA), CD11b (ICRF44), 
CD11c (B-ly6), CD14 (322A-1), CD16 (3G8), CD19 
(HIB19), CD20 (2H7), CD34 (581), CD45 (HI30), CD56 
(MEM188), CD123 (6H6), CXCR4 (12G5), and HLA-DR 
(L243). Dead cells were identified and excluded using DAPI 
staining. Lung, blood, and BM monocytes were identified as 
CD45+CD115+cKit−Ly6G−Lineage (CD3, CD19, CD45R, 
and NK1.1) negative and Ly6ChiCD43− or Ly6CloCD43+ 
according to the subset in mice and human BM classical 
monocytes identified as CD14+CD16−CD11b+CD34−HLA-
DR+Lineage− (CD3, CD10, CD19, CD20, CD56, and 
CD123). Cells were acquired on a BD LSR II flow cytometer 
(BD) using FAC SDiva Software, and data were analyzed using 
FlowJo Software (Tree Star). Total number of cells collected 
from blood or each tissue/organ was quantified using count 
beads (CountBright; Life Technologies) according to the 
manufacturer’s protocol. CXCR4 expression on monocytes 
was quantified as median fluorescent intensity (MFI) and 
normalized by subtracting the fluorescence minus one (FMO) 
control. For cell sorting, BM cells were sorted using a FAC 
SAria II (BD) to achieve >98% purity.
Brdu pulsing and proliferation assays
For in vivo assays, mice were administered 1.5 mg BrdU (BD) 
via intraperitoneal injection at indicated time points for cell 
tracking or for 30 min to assess their proliferative capacity. 
For in vitro cell proliferative assays, human BM cells were 
pulsed with 10 µM of BrdU for 45 min. To detect BrdU in-
corporation into monocytes, cells were surface-stained, fixed, 
permeabilized, and subjected to intracellular staining with 
FITC-conjugated anti-BrdU antibody, together with 7-AAD 
for cell cycle analysis, according to the manufacturer’s proto-
col (BrdU Flow kit; BD) before analysis by flow cytometry. 
The Fucci transgenic mouse model, in which cells in the S/
G2/M phase of the cell cycle were labeled with a green-emit-
ting fluorescent protein, was also used to identify proliferating 
cells through flow cytometry.
In vivo bead uptake
The ability of cells to uptake beads in vivo was assessed as 
previously described (Tacke et al., 2007). In brief, 0.5 µm 
Fluoresbrite polychromatic red microspheres (2.5% solids 
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[wt/vol]; Polysciences Inc.) were diluted 1:25 in PBS, and 
250 µl of the solution was injected into the lateral tail vein of 
mice. After 4 h, mice were sacrificed and BM was collected, 
flushed, and stained with antibodies to distinguish the differ-
ent monocyte cell populations.
Adoptive transfer of BM monocytes
Femurs and tibias were harvested from CD45.1 mice and 
flushed with ∼5  ml PBS containing 3% FCS. RBCs were 
lysed and the remaining cells were resuspended in sterile PBS. 
A total of 10 million CD45.1 donor cells were adoptively 
transferred into CD45.2 recipient mice that were simulta-
neously treated with AMD3100 or PBS. Recipient mice 
were euthanized at the time points indicated in the respec-
tive figures, and the perfused femurs were harvested for flow 
cytometric identification of donor monocyte (CD45.1) se-
questration into the BM of recipient animals (CD45.2). 
For intrafemoral transfer of BM Ly6Chi monocyte subsets, 
sorted 5 × 105 CD45.1+ CXCR4hi were suspended in PBS 
and were transferred into the left femur of CD45.2+ mice 
via an insulin syringe with a short needle (BD). At 8 and 
24 h after cell transfer, BM femurs were collected, and the 
resulting cell suspensions were analyzed by flow cytometry 
to establish the phenotype of the CD45.1+ progeny of the 
transferred cell populations.
dimensionality reduction using t-Sne 
and automatic clustering
BM Ly6Chi monocytes were manually gated from multicolor 
flow cytometry data. as shown in Fig. 1 A, and were exported 
in a FCS file. In this study, t-Distributed Stochastic Neighbor 
Embedding (t-SNE) dimensionality reduction was performed 
using bh_tsne, an implementation of t-SNE via Barnes-Hut 
approximations. R was used as an interface to execute bh_
tsne, as previously described (Becher et al., 2014). K-means 
automatic clustering was performed using CYT in Matlab. 
90,000 events were used for t-SNE dimensionality reduction.
transcriptomics
cMoP, Ly6ChiCXCR4hi, Ly6ChiCXCR4lo, and Ly6Clo mono-
cytes were sorted according to the gating strategy shown in 
Fig. 2 A. After sorting, cells were incubated for 3 h in RPMI 
+ 10% FCS and were then subjected to RNA isolation. Total 
RNA was extracted using Arcturus PicoPure RNA Isola-
tion kit according to the manufacturer's protocol. All mouse 
RNAs were analyzed on Perkin Elmer Labchip GX system 
for quality assessment with RIN > 7.9. cDNA libraries were 
prepared using 2 ng of total RNA and 1  µl of a 1:50,000 
dilution of ERCC RNA Spike in Controls (Ambion) using 
SMA RTSeq v2 protocol (Picelli et al., 2014), except for the 
following modifications: (1) use of 20 µM TSO; and (2) use 
of 250 pg of cDNA with 1/5 reaction of Illumina Nextera 
XT kit. The length distribution of the cDNA libraries was 
monitored using DNA High Sensitivity Reagent kit on the 
Perkin Elmer Labchip. All eight samples were subjected to an 
indexed PE sequencing run of 2 × 51 cycles on an Illumina 
HiSeq 2500 Rapid mode (14 samples/lane).
RNA-Seq data in the form of FAS TQ files were sub-
sequently mapped to the mouse genome build mm10 using 
the STAR alignment software. The mapped reads were then 
counted using featureCounts (part of Subread package) based 
on the GEN CODE M9 annotations. The raw counts were 
then used for a differential gene expression analysis (DEG) 
using edgeR (R version 3.1.2) with adjusted P < 0.05 and 
fold change >2 to identify genes differentially regulated in 
monocyte subsets. A filter for genes having a mean count of 
at least 10 was done to eliminate low expressing and non-
expressing genes before DEG analysis. PCA of samples was 
done using log2CPM (count per million reads) values of 
all detected genes. PCA, volcano plot, and heat maps were 
done in R version 3.1.2. Pathway analysis of DEGs was done 
using IPA software (Qiagen).
computational inference of developmental path
CMap (Lamb et al., 2006) analysis was performed using DEGs 
between Ly6ChiCXCR4lo and Ly6Clo monocytes. Positive 
CMap scores indicate enrichment of Ly6Clo signature genes, 
whereas negative CMap scores indicate enrichment of Ly6Chi 
signature genes. R package seriation (Hahsler et al., 2008) was 
used to find a suitable linear order for cMoP, CXCR4hi, and 
CXCR4lo Ly6Chi monocytes. Six different seriation methods, 
including TSP, R2E, ARSA, HC, GW, and OLO, were applied. 
TSP, ARSA, and OLO produced the best and identical results 
with regard to the shortest path length, minimal AR events, 
and minimum Moore stress. Seriation analysis was done using 
log2CPM values of all detected genes. PCA, CMap, and se-
riation analyses suggest a developmental path from cMoP to 
CXCR4hi, followed by CXCR4lo Ly6Chi monocyte.
Wanderlust was executed using CYT in Matlab, as 
previously described (Bendall et al., 2014). Wanderlust was 
run on six phenotypic markers: CXCR4, CD31, CD16/32, 
CX3CR1, CCR2, and CD11b, using the following parame-
ters: number of neighbors l = 30, k = 5, number of landmarks 
nl = 20, number of graphs to generate ng = 25, distance met-
ric = angular. The starting point (early events) consisted of 
selected Ly6Chi cells that expressed high levels of CXCR4, 
CD31, and CD16/32, as observed on cMoPs, which is the 
most direct progenitor of BM Ly6Chi monocytes. 90,000 
events were used for Wanderlust analysis.
Parabiosis and BM chimeric mice
Female mice were anesthetized using 2.5% Avertin (15 ml/
kg), shaved at the corresponding lateral sides of the body, and 
then surgically joined as previously described (Hashimoto et 
al., 2013). After surgery, the mice were treated with Baytril 
(0.05–2 mg/kg s.c.) and Buprenorphine (5–20 mg/kg s.c.) 
and allowed to recover for 8 wk. Since Lyz2creCxcr4fl and 
Cxcr4WHIM mice exhibit steady-state monocytosis and mono-
cytopenia, respectively, parabiosis with WT animals results in 
unequal exchange of circulating leukocytes (Fig. 6 C); the re-
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sults of these experiments were hence represented as a homing 
ratio to control for differences in absolute cell numbers be-
tween these mice. To determine the number of cells that had 
infiltrated a given organ, the number of nonhost cells present 
in that organ was divided by the total number of nonhost cells 
present in the host circulation (expressed as the homing ratio). 
To determine the total number of circulating cells, the blood 
volume present in an individual mouse was calculated using 
the formula: y = 0.0715 x, where y and x represent the blood 
volume (milliliters) and body weight (grams), respectively, as 
previously described (van Furth and Sluiter, 1986).
To generate BM chimeric mice, 6-wk-old WT and 
Tlr4−/− mice were irradiated with two doses of 550 rad 
spaced 3  h apart and reconstituted with BM from WT or 
Tlr4−/− mice under sterile conditions. Recipient mice were 
analyzed 6 wk after irradiation, and number of Ly6Chi mono-
cytes were quantified 1 h after administration of LPS.
Scanning electron microscopy
Sorted CXCR4hi and CXCR4lo monocytes were seeded 
onto coverslips and incubated at 37°C, 5% CO2, for 3 h to 
allow cell adhesion onto coverslips. Cells were fixed with 
2.5% Glutaraldehyde (Sigma-Aldrich) in PBS, washed, and 
post-fixed in 1% Osmium tetroxide (Electron Microscopy 
Services) in PBS, and then dehydrated in ethanol and pro-
cessed by critical point drying (EM CPD030; Leica). Finally, 
samples were sputter-coated with gold using an EM SCD050 
(Leica) and imaged on the JSM-6701F, JEOL scanning elec-
tron microscope at 4,000 × magnification. 60–70 cells were 
acquired for each tested group and representative images of a 
typical phenotype were presented in the figure.
Intravital multiphoton imaging of lung
Imaging of the lung was performed as previously described 
(Looney et al., 2011). In brief, mice were anaesthetized with 
a cocktail of ketamine and xylazine before cannulation of 
the trachea to allow connection to a mechanical ventilator 
(tidal volume, ∼8–10 µl/g body weight; respiratory rate, ∼120 
breaths per minute; MiniVent 845; Hugo Sachs Elektronik). 
Mice were then placed onto a heat pad to maintain body 
temperature at 37°C, followed by the removal of skin, mus-
cle, and two rib bones to expose the lung. A custom-made 
vacuum window ring was used to immobilize the lung via 
application of a negative pressure vacuum (∼40 mmHg). To 
label the pulmonary vasculature, 70kD TRI TC-conjugated 
dextran (250 µg in 100 µl saline; Sigma-Aldrich) or Evan’s 
blue (50 µg in 50 µl sterile PBS) was administered i.v. into 
mice. Experimental groups consisted of mice administered 
with AMD3100 s.c., LPS i.v., or a combination of AMD3100 
and LPS administered together via the different routes. Im-
aging of the lung began 45 min after single treatment with 
AMD3100 or LPS, whereas co-treatment of both AMD3100 
and LPS were imaged at 2  h into AMD3100 and 45 min 
into LPS simultaneously. For the visualization of monocyte 
subsets, 4 µg of Ly6B.2-PE (Novus Biologicals) were admin-
istered i.v. in Cx3cr1gfp/+ mice (Fig. 8, E and F). Experiments 
were performed at 880 or 990 nm excitation and 364 × 364 
µm images were acquired in fast mode over a period of 30 
min using a 4-µm z-step size with an approximate depth of 20 
µm. After acquisition, images were averaged to match respi-
ratory movements, and drifts during imaging were corrected 
where necessary (FIJI software). Images were subsequently 
transformed into time series movies using Imaris. Tracking 
of GFP+ cells was performed semiautomatically using Imaris 
spot-tracking algorithms, and mean velocity was extracted. 
The duration of GFP+ cell adherence in the lung vasculature 
was tabulated manually.
Localization of intravascular lung monocytes
Intravascular staining of lung monocytes was performed in 
vivo according to a previously described protocol (Ander-
son et al., 2014). In brief, mice were anaesthetized by iso-
flurane inhalation and APC-conjugated anti-CD45.2 (clone 
104; eBioscience) was administered i.v. (4 µg antibody in 
200 µl saline). The antibody was allowed to circulate for 3 
min before the mice were euthanized. Lungs were removed 
en bloc and processed immediately in an excess volume of 
PBS containing 3% FCS and 2  mM EDTA to dilute any 
excess antibody. FITC-conjugated anti-CD45.2 (clone 104; 
eBioscience) was included in the antibody-staining panel to 
identify extravascular cells.
Lung efflux assay
The method used for tandem blood sample collection from 
the carotid artery and vena cava has been described previously 
(Devi et al., 2013). In brief, mice were anesthetized with iso-
flurane and a midline incision was performed on the neck to 
expose the underlying carotid artery. A microvascular clamp 
was applied to the artery, which was then cannulated by inser-
tion of EDTA-filled polyethylene 10 tubing (inner diam, 0.28 
mm; outer diam, 0.61 mm). After securing the cannula with 
a surgical suture, the clamp was released and ∼40 µl of arte-
rial blood was collected into an Eppendorf tube. Blood was 
simultaneously drawn from the inferior vena cava using a 26-
gauge needle attached to a prefilled EDTA syringe. Samples 
were collected 1 h after LPS injection, or 2 h after AMD3100 
treatment. For mice that were cotreated with AMD3100 and 
LPS, the CXCR4 inhibitor was administered 1 h before in-
jection of LPS, and blood sample collection took place an 
additional 1 h later. Both arterial and venous blood samples 
were subsequently analyzed by flow cytometry.
For lung efflux assays done on nonhuman primates, all 
experiments were performed on adult female Macaca fas-
cicularis at the Singhealth Experimental Medicine Center 
(accredited by the Association for Assesment and Accrediation 
of Laboratory Animal Care) under approval #2012/SHS/692 
from the Institutional Animal Care and Use Committee of 
Singapore, as previously described (Devi et al., 2013). In brief, 
midline laparotomy was performed under general anesthesia 
and ∼1 ml of blood was each collected from the abdominal 
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aorta and inferior vena cava at baseline and hourly intervals 
after s.c. administration of AMD3100 (0.5 mg/kg). Mono-
cyte numbers were determined using a Hematology Ana-
lyzer (Beckman-Coulter).
The number of monocytes leaving the pulmonary 
circulation (termed net release) was calculated by sub-
tracting the number of monocytes present in the venous 
blood sample from the number of monocytes present in 
the arterial blood sample.
Pulmonary vascular permeability assay
To assess the influence of monocytes or CXCR4-signaling 
on pulmonary vascular permeability, we used a LPS-Zymo-
san induced model of ALI (O’Dea et al., 2009). For the in-
duction of ALI, mice were administered i.v. with 10 ng of 
LPS for 2 h. Subsequently, 150 µg in 100 µl of Zymosan-A 
(Sigma-Aldrich) was resuspended with 5 µl per g of 10 mg/
ml of Evans blue (Sigma-Aldrich) and injected i.v. into mice. 
Mice were sacrificed 1 h later and lungs were perfused with 
PBS using a peristaltic pump (MIN IPU LS 3, Gilson). Lungs 
were weighed and Evans blue was extracted from the lung 
by incubating samples in 1 ml of N,N-dimethlyformamide 
(Sigma-Aldrich) at 37°C overnight. The supernatant was sep-
arated by centrifugation at 5,000 g for 30 min. The concen-
tration of Evans blue in lung homogenate supernatants was 
quantified by a dual wavelength spectrophotometric method 
at absorptions of 620 and 740 nm, which allows for correc-
tion of contaminating heme pigments using the following 
formula: E620 (corrected) = E620 − (1.426 × E740 + 0.030)
chemotaxis assay
Femurs and tibias were harvested from C57BL/6 mice and 
flushed with ∼5 ml of PBS containing 3% FCS. RBCs were 
lysed and the resultant cells were suspended in sterile PBS 
for labeling with antibodies against CD11b, CD45, CD115, 
CXCR4, Flt3, cKit, and Ly6C, as well as an exclusion cock-
tail of antibodies against unwanted lineages (CD3, CD45R/
B220, Ly6G, and NK1.1). BM monocytes were identified as 
Lin−Flt3−cKit−CD115+Ly6Chi cells that displayed either a 
CXCR4hi or CXCR4lo phenotype. The CXCR4hi and CX-
CR4lo subsets were then sorted at high speed using a BD 
FAC SAria III apparatus (BD). A total of 105 sorted monocytes 
were transferred onto the top layer of a polycarbonate mem-
brane with 3 µm pore size (Transwell; Corning), before being 
placed into lower chambers containing 0–50 ng of recombi-
nant CCL2 (R&D Systems) and incubated at 37°C for 2 h. 
After incubation, the cells in the bottom chamber were har-
vested and analyzed by flow cytometry to determine the per-
centage of migrated monocytes (expressed as a proportion of 
the total cells that were initially loaded into the top chamber).
cLP-induced sepsis
Experimental procedures were performed as previously de-
scribed (Rittirsch et al., 2009). In brief, the peritoneal cav-
ity was exposed under ketamine/xylazine anesthesia and the 
cecum was exteriorized. ∼80% of the cecum was ligated distal 
of the ileo-cecal valve using a nonabsorbable 7–0 suture. A 
23-gauge needle was used to perforate the distal end of the 
cecum, and a small drop of feces was extruded through the 
puncture before being relocated into the peritoneal cavity. 
The peritoneum was closed and subsequently treated with 
saline and Buprenorphine (5–20 mg/kg s.c.) via s.c. injection. 
Age-matched controls were included for all procedures.
Statistical analysis
Statistical analyses were performed using Prism software 
(GraphPad). Data were tested using either Student’s t test 
(normal distribution) or ANO VA (one-way or two-way as 
appropriate), as indicated in the respective figure legends. P < 
0.05 was considered significant.
Accession nos.
All RNA-sequencing data have been deposited at the Na-
tional Center for Biotechnology Information Gene Expres-
sion Omnibus public database under accession no. GSE86079.
online supplemental material
Fig. S1 shows heat maps of genes that are significantly and 
differentially expressed between cell subsets of the monocyte 
developmental pathway. Fig. S2 shows detailed histograms 
of cell surface marker expression for distinguishing mono-
cyte subsets. Fig. S3 shows gating strategy for the analysis of 
CXCR4 expression on BM Ly6Chi monocytes. Fig. S4 shows 
gating strategy of blood monocytes in mice. Video 1 shows 
monocyte margination in the pulmonary vasculature. Video 2 
shows the visualization of Ly6Chi monocytes in a Cx3cr1gfp/+ 
mouse with an anti-Ly6B.2 antibody.
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